Spots Global Cancer Trial Database for A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
Official Title: A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
Study ID: NCT04008524
Interventions
Study Description
Brief Summary: This project is intended to provide CAR-T cell therapy products for patients with severely life-threatening relapsed and refractory hematological malignancies. These patients have been previously treated sufficiently, currently have no other treatment methods available, and do not meet the inclusion criteria of other clinical trial projects in the process of subject recruitment or meet their exclusion criteria. This project is designed to meet the urgent clinical needs of individual patients.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institute of Hematology & Blood Diseases Hospital, Tianjin, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
